Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
-
Authors :
Liu X; Department of Epidemiology and Health Statistics, School of Public Health, Ningxia Medical University, Yinchuan, Ningxia, China.; Yang C
Subjects: Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/epidemiology ; Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/etiology ; Obesity, Metabolically Benign*/Obesity, Metabolically Benign*/Obesity, Metabolically Benign*/complications
-
Source:
Metabolic syndrome and related disorders [Metab Syndr Relat Disord] 2023 Aug; Vol. 21 (6), pp. 306-313.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101150318 Publication Model: Print Cited
Record details
-
Authors :
Chen D; Department of Electrocardiogram, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.; Artificial Intelligence Institute, Qilu University of Technology (Shandong Academy of Sciences), Jinan, Shandong, China.
Subjects: Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/complications ; Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/diagnosis ; Heart Failure*
-
Source:
Metabolic syndrome and related disorders [Metab Syndr Relat Disord] 2024 Apr; Vol. 22 (3), pp. 161-169. Date of Electronic Publication: 2024 Jan 29.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101150318 Publication Model: Print-Electronic
Record details
-
Authors :
Spasovski G; Department of Nephrology, Medical Faculty, University Sts. Cyril and Methodius, Skopje, North Macedonia.; Rroji M
Subjects: Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy
-
Source:
Metabolic syndrome and related disorders [Metab Syndr Relat Disord] 2024 Apr; Vol. 22 (3), pp. 170-178. Date of Electronic Publication: 2024 Feb 21.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101150318 Publication Model: Print-Electronic
Record details
-
Authors :
Angelone T; Cellular and Molecular Cardiovascular Pathophysiology Laboratory, Department of Biology, Ecology and Earth Sciences (DiBEST), University of Calabria, Rende, Italy.; National Institute of Cardiovascular Research (INRC), Bologna, Italy.
Subjects: Selenium*/Selenium*/Selenium*/metabolism ; Cardiovascular Diseases*; Humans
-
Source:
Antioxidants & redox signaling [Antioxid Redox Signal] 2024 Mar; Vol. 40 (7-9), pp. 369-432.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100888899 Publication Model: Print Cited
Record details
Subjects: Cardiovascular Diseases*; Humans ; Risk Factors
-
Source:
Journal of palliative medicine [J Palliat Med] 2024 Feb; Vol. 27 (2), pp. 288.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9808462 Publication Model: Print Cited Medium:
Record details